On the global dynamics of a model for tumor immunotherapy

Mathematical Biosciences and Engineering

Volumn 6, Issue 3, 2009, Pages 573-583

  Kirschner, Denise ^a   Tsygvintsev, Alexei ^b  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNITÉ DE MATHÉMATIQUES PURES ET APPLIQUÉES   (France)

Author keywords

Cancer; Dynamical systems; Immunotherapy; Lyapunov functions

Indexed keywords

EID: 70349641183     PISSN: 15471063     EISSN: 15510018     Source Type: Journal    
DOI: 10.3934/mbe.2009.6.573     Document Type: Article

References (12)

1. J. A. Adam and C Bellomo, "A Survey of Models for Tumor-Immune System Dynamics," Birkhauser, Boston, MA 1996.
2. D. Kirechner, J. Arciero and T. Jackson, Mathematical model of tumor-immune evasion and siRNA treatment, Discrete and Cont. Dyn. Systems, 4 (2004), 39-58.
3. D. Kirschner and J. Panetta, Modeling immunotherapy of the tumor-immune interaction, J Math Biol, 37 (1998), 235-252.
4. F. Nani and M. Ogureli, Modelling and simulation of Rosenberg-type adoptive cellular immunotherapy, IMA Journal of Mathematics Applied in Medicine & Biology, 11 (1994), 107-147.
5. H. Rabinowich, M. Banks, Torten E. Reichert, Theodore F. Logan, J. M. Kirkwood and T. L. Whiteside, Expression and activity of signaling molecules n T lymphocytes obtained from patients with metastatic melanoma before and after interleukin 2 therapy, Clinical Cancer Research, 2 (1996), 1263-1274.
6. S. A. Rosenberg and M. T. Lotze, Cancer immunotherapy using interleukin-2 and interleukin-2-activated lymphocytes, Annual Review of Immunology, 4 (1986), 681-709.
7. S. A. Rosenberg, J. C. Yang, S. L. Topalian, D. J. Schwartzentruber, J. S. Weber, D. R. Parkinson, C. A. Seipp, J. H. Einhorn and D. E. White, Treatment of 283 consecutive patients with metastatic melanoma or renal cell cancer using high-dose bolus interleukin 2, JAMA, 271 (1994), 907-913.
8. M. Rosenstein, S. E. Ettinghousen and S. A. Rosenberg, Extravasion of intravascular uid mediated by the systemic administration of recombinant interleukin 2, Journal of Immunology, 137 (1986), 1735-1742.
9. M. Chaplain and A. Anderson, Mathematical modeling of tumor-induced angiogenesis: Network and growth structure, Journal of Cancer Treatment Research, 117 (2004), 51-75.
10. B. Ribba, K. Marron, Z. Agur, T. Alarcon and P.K. Maini, A mathematical model of Dox- orubicon treatment efficacy for non-Hodgkin's lymphoma investigation of the current protocol through theoretical modeling results, Bulletin of Mathematical Biology, 67 (2005), 79-99.
11. J. Arciero, T. Jackson and D. Kirschner, A mathematical model of tumor immune evasion and siRNA treatment, Discrete and Continuous Dynamical Systems, Series B, 4, (2004), 39-58.
12. T. Burden, J. Ernstberger and K. R. Fister, Optimal Control Applied to Immunotherapy, Discrete and Continuous Dynamical systems, 4 (2004), 135-146.